Evidence map›Paper›PMID 35279967›Full record

ArticleCell journal2022

Ribosome Profiling: A Useful Approach to Discover Hidden Corners of SARS-CoV-2.

Milad Zandi, Emad Behboudi, Parisa Zeinali, Saber Soltani, Mohammad Reza Shojaei

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Milad ZandiDepartment of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. Email: miladzandi416@gmail.com.
Emad BehboudiDepartment of Microbiology, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
Parisa ZeinaliDepartment of Biochemistry and Biophysics, School of Medicine, Metabolic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
Saber SoltaniDepartment of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Mohammad Reza ShojaeiDepartment of Microbiology, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Following SARS-CoV-2 China epidemic in the December 2019, researches have attended to the genome of novel coronavirus. Hidden corners of SARS-CoV-2, maybe a shiny way to discover its pathogenicity and virulence. To design therapeutic agents, it is critical to map the complete repertoire of viral-translated proteins. Ribosome profiling is considered as a snapshot of all active ribosomes in a cell at a specific time point.

Indexed as

GenomeOpen Reading FramesRibo-seqSARS-CoV-2

Identifiers

PMID35279967
PMCPMC8918269

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.